Showing results (671-680 of 716) with videos related to

Sort By:
Pageof 72
Neurosurgery|April 16, 2021
Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum InvestigatorsEdjah K Nduom, Melanie Hayden Gephart, Milan G Chheda, et al.
Cancer Discovery|February 28, 2024
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector PopulationAnthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler, et al.
Nature Communications|March 23, 2023
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancerKelsy C Cotto, Yang-Yang Feng, Avinash Ramu, et al.
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.
Annals of Surgery|September 25, 2025
Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III TrialZachary J Kastenberg, Sanjeev A Vasudevan, Lucy Dolmadjian, et al.
Journal of Neurosurgery|October 9, 2020
Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgeryAmar S Shah, Peter T Sylvester, Alexander T Yahanda, et al.
Cancer Immunology Research|October 31, 2023
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology SymposiumChristopher Alvarez-Breckenridge, Kristin G Anderson, Ana Luisa Correia, et al.
NPJ Digital Medicine|September 1, 2022
A method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19Md Mobashir Hasan Shandhi, Peter J Cho, Ali R Roghanizad, et al.
Neurosurgery|August 18, 2020
Using Histopathology to Assess the Reliability of Intraoperative Magnetic Resonance Imaging in Guiding Additional Brain Tumor Resection: A Multicenter StudyAmar S Shah, Alexander T Yahanda, Peter T Sylvester, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent GlioblastomaLakshmi Nayak, Nathan Standifer, Jorg Dietrich, et al.
Pageof 72